- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00065364
Improving Brain Development in Medically Healthy Premature Infants
Neurodevelopment and Experience: Behavior, Quantitative EEG and MRI
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
From 28 to 33 weeks' gestation, significant neurological reorganization takes place, initiating fetal behavioral individuality and capacity for extrauterine survival. Infants born at this transitional stage exhibit unexpectedly significant brain dysfunction as they develop and age. The majority of these infants will develop psychomotor, cognitive, and attentional function deficits as well as emotional vulnerability and substandard school performance. Research suggests that these symptoms are due to a central deficit in frontal lobe processing of complex information. This central deficit may result from increased vulnerability of cerebral white matter during the last trimester of gestation, its phase of most rapid development. Persistent stress due to inappropriate sensory stimulation may contribute to alteration of early brain structure and function. This study will identify specific adaptations of the preterm brain to the transient NICU experience in order to estimate the potential of such experience in remodeling neuroanatomical structure and neurodevelopmental function. Further, the study will evaluate a program of specialized developmental care within the NICU environment.
The study's specialized developmental care model views the preterm infant as a fetus and attempts to reduce the discrepancy between the technological hospital environment and the mother's womb. A developmental specialist team will support the NICU caregivers. The developmental specialists will observe the infant's behavior and use these observations to formulate descriptive neurobehavioral reports and suggestions, to structure caregiving procedures in coordination with the infant's sleep/wake cycle, and to maintain the infant's well-regulated behavioral balance. The goal of the intervention is to promote the infant's strengths while reducing the infant's self-regulatory vulnerability.
Sixty medically healthy infants born between 28 and 33 weeks' gestation will be randomly assigned to standard NICU care or specialized developmental care. Preterm infants will be compared to 30 healthy full term infants. All infants will be assessed at 42 weeks' postconceptional age in three neurodevelopmental domains: neurobehavioral function, neuroelectrophysiological function, and neuroanatomic structure. Assessments will focus on distinct regions of the brain (occipital and frontal lobes) and the corpus callosum (which connects the right and left sides of the brain).
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for Preterm Infants
- Born at Brigham and Women's Hospital (BWH), Boston
- Family residence in the greater Boston area
- Gestational age at birth of 28 to 33 weeks assessed by mother's dates, the Ballard assessment, and prenatal ultrasound as available
- Birthweight, height, and head circumference appropriate (10th to 90th percentile) for gestational age
- 1 and 5 minute Apgar >= 7
- Endotracheal intubation and mechanical ventilator support, including continuous positive airway pressure (CPAP), for < 48 hours after delivery
- Normal cranial ultrasound(s) within first 7 days of life
- Mother between 15 and 39 years old
- Telephone access
- Sufficient English language facility to assure successful communication and follow-up
Exclusion Criteria for Preterm Infants
- Use of dopamine or hydrocortisone
- Chromosomal or congenital abnormalities (e.g., Down's, Turner's, Klinefelter's syndromes)
- Congenital or acquired infections (e.g., TORCH, HIV, sepsis)
- Major maternal illness; diagnosed mental and/or emotional impairment; reported alcohol, nicotine, or illegal drug use and/or positive urine toxicity screen; or chronic medication treatment (e.g., synthroid, insulin, steroids)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
MRI
|
|
neurodevelopmental function
|
|
EEG
|
Collaborators and Investigators
Investigators
- Principal Investigator: Heidelise Als, PhD, Harvard University
Publications and helpful links
General Publications
- Als H, Duffy FH, McAnulty GB, Rivkin MJ, Vajapeyam S, Mulkern RV, Warfield SK, Huppi PS, Butler SC, Conneman N, Fischer C, Eichenwald EC. Early experience alters brain function and structure. Pediatrics. 2004 Apr;113(4):846-57. doi: 10.1542/peds.113.4.846.
- Rivkin MJ, Wolraich D, Als H, McAnulty G, Butler S, Conneman N, Fischer C, Vajapeyam S, Robertson RL, Mulkern RV. Prolonged T*2 values in newborn versus adult brain: Implications for fMRI studies of newborns. Magn Reson Med. 2004 Jun;51(6):1287-91. doi: 10.1002/mrm.20098.
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HD038261 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
-
Elgan Pharma Ltd.Terminated
-
Hôpital de la Croix-RousseUnknownPremature Birth of NewbornFrance
Clinical Trials on Newborn Individualized Developmental Care Assessment Program
-
University of AarhusNovo Nordisk A/S; Aarhus University HospitalCompleted
-
Boston Children's HospitalCompletedPrematurity | Intrauterine Growth RetardationUnited States
-
Eunice Kennedy Shriver National Institute of Child...Unknown
-
Ann & Robert H Lurie Children's Hospital of ChicagoTerminated
-
Boston Children's HospitalRecruitingInfant Development | Development Delay | CardiologyUnited States
-
University of YalovaCompletedSelf Efficacy | Premature | Maternal | AttachmentTurkey (Türkiye)
-
Boston Children's HospitalUnknown
-
UConn HealthNational Institute of Dental and Craniofacial Research (NIDCR)Active, not recruitingTemporomandibular Joint Disorders | Orofacial PainUnited States
-
Karen WondersCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsWithdrawnRelapsing-remitting Multiple Sclerosis